Nike Sales Miss Estimates as China Weakness and Competition Weigh on Turnaround
Earnings topped estimates, while the full-year outlook stayed soft.
Already have an account? Sign in.
Earnings topped estimates, while the full-year outlook stayed soft.
Tucows is selling Ting’s owned fiber markets to Clearwave, expected to remove $301.5 million in debt and move toward a simpler business.
Sellas Life Sciences’ galinpepimut-S vaccine reduced the risk of death by 41% in a Phase 3 AML trial, with median survival of 24 months.
Nike’s Full Stride Ahead plan targets $5 billion extra revenue by 2031, 12-14% margins, and $3–$3.50 adjusted EPS, led by performance sports.
Be the first to know when deals break, stocks move, or biotech headlines hit.